- Anadis
Anadis is a
biotechnology company based inMelbourne ,Australia that trades on theAustralian Stock Exchange with the symbol ANX. [Cite web|url=http://www.asx.com.au/asx/markets/PriceResults.jsp?method=get&template=F1001&ASXCodes=ANX|title=Anadis|publisher=Australian Stock Exchange|date=2007-06-05 ] an ADR Level I program was initiated in late 2007, and the company is quoted over the counter in the U.S. with the ticker ANDIYThe company focused on
antigen -primed, dairy-derived health products. Anadis’ proprietary, technology enables it to rapidly develop polyclonal antibody and other proteins-based solutions to a range of important diseases. The all-natural bovinecolostrum -derived platform, its regulatory classification as GRAS (Generally Regarded as Safe) when administered orally and the proprietary methods of manufacturing, allows for short time-frame from bench to market with high manufacturing scalability.With expertise in research, commercialisation and manufacturing Anadis specialises in innovative nutraceutical, pharmaceutical and related therapeutic technology products, including Oral and GI
Mucositis , Routine andAvian Influenza , -e.Coli Travellers' Diarrhoea (TD),Irritable Bowel Syndrome (IBS) andInflammatory Bowel Disease (IBD), andAnthrax containment.External links
* [http://www.anadis.com.au Official website]
References
Wikimedia Foundation. 2010.